| Literature DB >> 35814626 |
Marwa Ben Brahim1, Sondes Arfa1, Fadia Boubaker1, Jihen Chelly1, Wafa Ammari2, Sonia Hammami3,4, Fatma Arbi1, Olfa Berriche1,4.
Abstract
Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease characterized by widespread clinical manifestations and immunological disorders. A myriad of ocular manifestations can be seen in patients with SLE. The most vision-threatening complication is vaso-occlusive retinopathy including retinal vein occlusion (RVO). RVO associated with SLE is well described in the literature and its association with antiphospholipid antibodies is recognized. However, RVO as the initial manifestation of SLE is scarcely reported. Herein, we report the first case of recurrent RVO as the revealing manifestation of SLE in a 40-year-old male patient. He had two consecutive episodes of decreased vision. Ophthalmologic examination disclosed a branch retinal vein occlusion the first time and a central retinal vein occlusion the second time. The diagnosis of SLE was established based on clinical and immunological criteria. He was prescribed antiplatelet therapy, hydroxychloroquine at 5.5 mg/kg/day, and intravitreal anti-vascular endothelial growth factor (VEGF) antibodies regimen. He slowly improved under treatment. Copyright:Entities:
Keywords: Intra-vitreal anti-vascular endothelial growth factor antibodies treatment; Male patient; Retinal vein occlusion; Systemic Lupus Erythematosus; case report
Mesh:
Year: 2021 PMID: 35814626 PMCID: PMC9226707.4 DOI: 10.12688/f1000research.55189.4
Source DB: PubMed Journal: F1000Res ISSN: 2046-1402